Synthesis and Platelet-Activating Factor (PAF)-Antagonistic Activities of 1,4-Disubstituted Piperazine Derivatives.
作者:Hideto FUKUSHI、Hiroshi MABUCHI、Katsumi ITOH、Zen-ichi TERASHITA、Kohei NISHIKAWA、Hirosada SUGIHARA
DOI:10.1248/cpb.42.541
日期:——
platelet-activating factor (PAF) antagonists, we found that 1-(6-methoxy-3,4-dihydro-2-naphthoyl)-4- (3,4,5-trimethoxybenzyl)piperazine and its 4-(3,4,5- trimethoxybenzoyl)piperazine derivatives (1b, 2b) exerted in vitro and in vivo PAF-antagonistic activities. Modifications of the 1-acyl group, the substituent at the 4-position and the piperazine ring of 1a and 2b were examined and from this series 1-(2,3-dimethoxy-6
在筛选新型血小板活化因子(PAF)拮抗剂的过程中,我们发现1-(6-甲氧基-3,4-二氢-2-萘甲酰基)-4-(3,4,5-三甲氧基苄基)哌嗪及其4 -(3,4,5-三甲氧基苯甲酰基)哌嗪衍生物(1b,2b)在体内和体外具有PAF拮抗活性。检查了1a和2b的1-酰基,4-位取代基和哌嗪环的修饰,并从该系列的1-(2,3-二甲氧基-6,7-二氢-5H-苯并环庚烯-8-发现羰基++(+)-4-(3,4,5-三甲氧基苯甲酰基)哌嗪(2g)是最有效的PAF拮抗剂之一。